Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Mirati Therapeutics, Inc. (MRTX)

« Back to company index

MRTX Chatter Timeline

Stock Ticker for MRTX

Most Active Tweeters for MRTX

UserTweets
@Tickeron 5
@stock_titan 3
@StockNewsBot2 3
@FlashAlert_me 3
@BioBill2 2

Recent Tweets for MRTX

FlashAlert_me @FlashAlert_me
$MRTX [15s. delayed] filed SEC form 4: President & Head of R&D BAUM CHARLES M: Disposed 47,204 of Common Stock at… https://t.co/NdEIshjuFg
1:12am
fintel_io @fintel_io
Insider Charles M Baum reports selling 47,204 shares of $MRTX for a total cost of $6,287,687.46 https://t.co/zxM9YCPCTE #FNTL
1:12am
formwhisperscom @formwhisperscom
#FWSells $MRTX BAUM CHARLES M, President & Head of R&D of Mirati Therapeutics, Inc. sold 47,204 shares on 2021-12-0… https://t.co/7XbRrkkEUI
1:12am
LargeVoidBot @LargeVoidBot
12:00 New 52wk Lows: $MRTX $RPAY
December 3rd 2021, 5:12pm
bigpharmaguy @bigpharmaguy
RT @BioBill2: $mrtx Something that has piqued my interest is the potential combination of Mirati’s g12c inhibitor (adagrasib) and their MTA…
December 1st 2021, 9:12pm
BioBill2 @BioBill2
$mrtx Something that has piqued my interest is the potential combination of Mirati’s g12c inhibitor (adagrasib) and… https://t.co/ZAFmtVKt5f
December 1st 2021, 9:12pm
Uncletrade1 @Uncletrade1
$MRTX Awaiting buy Signal. Stock Trading Ideas by https://t.co/EAlF3EfmVW #Investing #trading https://t.co/b0l1ppfsCa
November 30th 2021, 12:11pm
RamUltraAlgo @RamUltraAlgo
Waiting for Buy signal on $MRTX https://t.co/h8xRPIaOo7
November 29th 2021, 5:11pm
BioBill2 @BioBill2
$mrtx has submitted their IND. $TNGX still expecting IND submission q4.
November 28th 2021, 5:11pm
TradeFlags @TradeFlags
#DeathCross $MRTX at 137.45 R8 HiLo 5% T1Y 216 buy 2.2 fwdPE -13.0 DIV N/A #Mirati The #stocks #trading #finance… https://t.co/KE0RX0Swrt
November 25th 2021, 5:11am
bullriders1 @bullriders1
$MRTX 141 Partnership with Verastem Oncology to evaluate Adagrasib/VS-6766 combo in mutant non-small cell lung canc… https://t.co/jWZUE3ltbC
November 24th 2021, 11:11pm
Tickeron @Tickeron
$MRTX's 10-day Moving Average broke below its 50-day Moving Average on November 9, 2021. View odds for this and oth… https://t.co/P6vqqct1wo
November 24th 2021, 11:11pm
Tickeron @Tickeron
Good move or bad move? $MRTX RSI Indicator left the oversold zone. #MiratiTherapeutics #stockmarket #stock… https://t.co/JXrEBGekez
November 24th 2021, 9:11pm
Tickeron @Tickeron
Do you agree with the A.I. prediction? $MRTX Aroon Indicator entered a Downtrend. #MiratiTherapeutics #stockmarket… https://t.co/HeA8eRp5b1
November 24th 2021, 6:11pm
ShortAlgoTrades @ShortAlgoTrades
$MRTX Awaiting buy signal. Trading simplified, free trial at https://t.co/jpmUt7BvVp https://t.co/gsak7I60C7
November 24th 2021, 2:11pm
1stOncology @1stOncology
#MiratiTherapeutics to Participate in the 4th Annual Evercore ISI #HealthCONxConference $MRTX https://t.co/4avGVzqDnT
November 24th 2021, 9:11am
newsfilterio @newsfilterio
Mirati Therapeutics to Participate in the 4th Annual Evercore ISI HealthCONx Conference $MRTX https://t.co/1SAawbnEpr
November 23rd 2021, 11:11pm
StockNewsBot2 @StockNewsBot2
$MRTX Mirati Therapeutics to Participate in the 4th Annual Evercore ISI HealthCONx Conference https://t.co/oL27ijaexV
November 23rd 2021, 9:11pm
stock_titan @stock_titan
$MRTX Mirati Therapeutics to Participate in the 4th Annual Evercore ISI HealthCONx Conference https://t.co/XMhTj2DfwR
November 23rd 2021, 9:11pm
RamUltraAlgo @RamUltraAlgo
Waiting for Buy signal on $MRTX https://t.co/uQl84Jj5I1
November 23rd 2021, 5:11pm
SweepCastApp @SweepCastApp
SweepCast alerted: $MRTX with Unusual Options Activity Alerted on $100 CALL Expiring: 03-18-2022 worth 29K? |? See more in profile
November 22nd 2021, 8:11pm
MarcJacksonLA @MarcJacksonLA
$MRTX $VSTM Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in… https://t.co/XJdsp67UMN
November 22nd 2021, 2:11pm
Briefingcom @Briefingcom
$MRTX: Mirati Therapeutics and Verastem (VSTM) announced a non-exclusive clinical collaboration agreement to... https://t.co/sV2IQ0JABk
November 22nd 2021, 2:11pm
MarketCurrents @MarketCurrents
$VSTM $MRTX - Mirati, Verastem to evaluate adagrasib/VS-6766 combination in non-small cell lung cancer https://t.co/kSMQoUbF0K
November 22nd 2021, 1:11pm
biostockinfo @biostockinfo
RT @BioStocks: $MRTX and $VSTM Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutant NSCLC
November 22nd 2021, 1:11pm
63_hyacinth @63_hyacinth
Mirati Therapeutics and Verastem announces collaboration agreement $MRTX $VSTM
November 22nd 2021, 12:11pm
FlashAlert_me @FlashAlert_me
$MRTX [15s. delayed]: Issued Press Release on November 22, 07:30:00: Mirati Therapeutics and Verastem Oncology Part… https://t.co/AKkyTjKhlV
November 22nd 2021, 12:11pm
OryoJohn @OryoJohn
$MRTX $VSTM: Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in… https://t.co/JfHAeUX9Rc
November 22nd 2021, 12:11pm
FlashAlert_me @FlashAlert_me
$MRTX [15s. delayed]: Issued Press Release on November 22, 07:30:00: Mirati Therapeutics and Verastem Oncology Part… https://t.co/Cxhuk4V1QM
November 22nd 2021, 12:11pm
BioStocks @BioStocks
$MRTX and $VSTM Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutant NSCLC
November 22nd 2021, 12:11pm
StockNewsBot2 @StockNewsBot2
$MRTX $VSTM Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in… https://t.co/SvKUsBx1fK
November 22nd 2021, 12:11pm
StockNewsBot2 @StockNewsBot2
$VSTM $MRTX Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in… https://t.co/Ydy2PElGkd
November 22nd 2021, 12:11pm
quantisnow @quantisnow
$MRTX $VSTM ? Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 i… https://t.co/DwlqCCEFyV
November 22nd 2021, 12:11pm
stock_titan @stock_titan
$MRTX $VSTM Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in… https://t.co/zBuTG7kNfC
November 22nd 2021, 12:11pm
stock_titan @stock_titan
$VSTM $MRTX Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in… https://t.co/E9uPOWkWxA
November 22nd 2021, 12:11pm
bthefirsttoknow @bthefirsttoknow
First out// $MRTX: Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6… https://t.co/TjIypfuioL
November 22nd 2021, 12:11pm
Tickeron @Tickeron
$MRTX's 10-day Moving Average moved below its 50-day Moving Average on November 9, 2021. View odds for this and oth… https://t.co/niPq5HZbF5
November 20th 2021, 7:11am
Tickeron @Tickeron
A.I.dvisor made a bearish call on $MRTX, netting in a 18.12% gain over 1 month #MiratiTherapeutics #stockmarket… https://t.co/3RT0TTM39i
November 20th 2021, 5:11am
MarcJacksonLA @MarcJacksonLA
$MRTX BMO Capital Markets Initiates Coverage On Mirati Therapeutics At Outperform, $187 PT https://t.co/0as1obZXkQ
November 19th 2021, 4:11pm
Briefingcom @Briefingcom
$MRTX: BMO Capital Markets starts at Outperform
November 19th 2021, 12:11pm
Jarvis_Alerts @Jarvis_Alerts
$MRTX [Mirati Therapeutics]: BMO Capital Initiates Coverage On Outperform Announces Price Target $187 Sign-up fre… https://t.co/OM2LOn9HOh
November 19th 2021, 12:11pm
Biotech2k1 @Biotech2k1
$MRTX has been a staple in my portfolio since LOXO was bought out on me. Its my top pick for KRAS as of now. They h… https://t.co/4KT4aeS0iN
November 19th 2021, 11:11am
SweepCastApp @SweepCastApp
SweepCast alerted: $MRTX with Unusual Options Activity Alerted on $180 CALL Expiring: 12-17-2021 worth 978K? |? Sta… https://t.co/kMSyJvDEQx
November 19th 2021, 11:11am
newsfilterio @newsfilterio
$MRTX BMO Capital analyst Evan Seigerman initiates coverage on Mirati Therapeutics with a Outperform rating and ann… https://t.co/HbDomXIv41
November 19th 2021, 10:11am
newsfilterio @newsfilterio
$MRTX BMO Capital analyst Evan Seigerman initiates coverage on Mirati Therapeutics with a Outperform rating and ann… https://t.co/WmN6iaQdlM
November 19th 2021, 10:11am
MarcJacksonLA @MarcJacksonLA
$MRTX BMO Capital Markets Initiates Coverage On Mirati Therapeutics At Outperform https://t.co/xKruSlBFiq
November 19th 2021, 12:11am
theflynews @theflynews
Amgen initiated with a Market Perform at BMO Capital $AMGN $MRTX https://t.co/y36zJ1WTjL
November 18th 2021, 9:11pm
63_hyacinth @63_hyacinth
Amgen initiated with a Market Perform at BMO Capital $AMGN $MRTX
November 18th 2021, 9:11pm
63_hyacinth @63_hyacinth
Mirati Therapeutics initiated with an Outperform at BMO Capital $MRTX
November 18th 2021, 9:11pm
YuZhu4 @YuZhu4
RT @algobotnews: Mirati Therapeutics submits IND application to FDA for MRTX1719 $MRTX
November 18th 2021, 1:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.